Furthermore, several studies demonstrated a significant correlation between serum hepcidin level, hepatic iron, and fibrosis in NAFLD/NASH patients (Valenti et al. 2010, Nelson et al. 2011, Nelson et al. 2012). This evidence concerns the gene HAMP and metabolic dysfunction-associated steatotic liver disease.